Olga Halle
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Type 3 innate lymphoid cells dominate the ILC compartment in endstage lung disease.
Journal: Frontiers in immunology
Published: September 30, 2025
Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis.
Journal: The European respiratory journal
Published: January 23, 2025
Single cell RNA sequencing reveals distinct clusters of Irf8-expressing pulmonary conventional dendritic cells.
Journal: Frontiers in immunology
Published: December 19, 2022
Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases.
Journal: Clinical & translational immunology
Published: October 22, 2021
IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease.
Journal: The European respiratory journal
Published: April 08, 2019
Clever-1 contributes to lymphocyte entry into the spleen via the red pulp.
Journal: Science immunology
Published: January 17, 2018
Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo.
Journal: Trends in immunology
Published: February 28, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026